VanEck Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.48M Sell
32,799
-76,052
-70% -$8.07M ﹤0.01% 852
2025
Q1
$13.5M Buy
108,851
+59,472
+120% +$7.38M 0.02% 395
2024
Q4
$6.08M Sell
49,379
-10,832
-18% -$1.33M 0.01% 613
2024
Q3
$6.69M Buy
60,211
+6,157
+11% +$684K 0.01% 557
2024
Q2
$5.77M Buy
54,054
+2,361
+5% +$252K 0.01% 539
2024
Q1
$6.23M Sell
51,693
-26,315
-34% -$3.17M 0.01% 519
2023
Q4
$9.6M Sell
78,008
-7,514
-9% -$924K 0.02% 380
2023
Q3
$11.1M Sell
85,522
-27,138
-24% -$3.51M 0.02% 326
2023
Q2
$14M Buy
112,660
+46,908
+71% +$5.81M 0.03% 298
2023
Q1
$9.62M Sell
65,752
-45,271
-41% -$6.62M 0.02% 359
2022
Q4
$17.7M Buy
111,023
+15,825
+17% +$2.52M 0.05% 256
2022
Q3
$12.7M Sell
95,198
-42,293
-31% -$5.64M 0.04% 277
2022
Q2
$21.5M Buy
137,491
+62,815
+84% +$9.8M 0.06% 238
2022
Q1
$11.6M Buy
74,676
+1
+0% +$156 0.02% 342
2021
Q4
$9.51M Buy
74,675
+15,650
+27% +$1.99M 0.02% 384
2021
Q3
$7.69M Buy
59,025
+19,836
+51% +$2.58M 0.02% 384
2021
Q2
$6.96M Buy
39,189
+540
+1% +$95.9K 0.02% 400
2021
Q1
$6.35M Sell
38,649
-20,768
-35% -$3.41M 0.02% 401
2020
Q4
$9.81M Sell
59,417
-5,519
-8% -$911K 0.03% 314
2020
Q3
$9.26M Buy
64,936
+7,446
+13% +$1.06M 0.03% 273
2020
Q2
$6.34M Buy
57,490
+5,104
+10% +$563K 0.02% 312
2020
Q1
$5.23M Buy
52,386
+8,611
+20% +$859K 0.03% 295
2019
Q4
$6.54M Buy
43,775
+10,761
+33% +$1.61M 0.03% 326
2019
Q3
$4.23M Sell
33,014
-18,847
-36% -$2.41M 0.02% 361
2019
Q2
$7.39M Sell
51,861
-251
-0.5% -$35.8K 0.04% 272
2019
Q1
$7.45M Sell
52,112
-27,559
-35% -$3.94M 0.04% 264
2018
Q4
$9.88M Buy
79,671
+6,502
+9% +$806K 0.05% 227
2018
Q3
$12.3M Buy
73,169
+1,474
+2% +$248K 0.06% 230
2018
Q2
$12.4M Sell
71,695
-5,858
-8% -$1.01M 0.06% 218
2018
Q1
$11.7M Sell
77,553
-9,366
-11% -$1.41M 0.06% 224
2017
Q4
$11.7M Buy
86,919
+3,709
+4% +$499K 0.06% 222
2017
Q3
$12.2M Buy
83,210
+32,360
+64% +$4.73M 0.06% 229
2017
Q2
$7.91M Sell
50,850
-9,199
-15% -$1.43M 0.04% 240
2017
Q1
$8.72M Buy
60,049
+34,276
+133% +$4.97M 0.04% 239
2016
Q4
$2.81M Sell
25,773
-6,346
-20% -$692K 0.01% 361
2016
Q3
$3.9M Buy
32,119
+4,230
+15% +$514K 0.02% 321
2016
Q2
$3.94M Buy
27,889
+6,189
+29% +$875K 0.02% 301
2016
Q1
$2.83M Buy
21,700
+945
+5% +$123K 0.02% 307
2015
Q4
$2.92M Buy
20,755
+1,905
+10% +$268K 0.02% 275
2015
Q3
$2.5M Buy
18,850
+2,677
+17% +$355K 0.02% 298
2015
Q2
$2.85M Buy
+16,173
New +$2.85M 0.02% 330